$7.17 - $7.31 - guess shorts would be forced to cover.
At these low volume about 10 days to cover - that would be interesting but chances we clear $7 are about
The chances we clear $7 are probably pretty good.
Sometime in the next few months, maybe the next few weeks, we receive the phase 1 data on the Freidrichs ataxia study. Would not like to be short RGEN when that happens. Could be brutal.
Well whatever happens RGEN feels much better at this share price close to $7.
We wait ha!